Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [1] IL28B and the Control of Hepatitis C Virus Infection
    Balagopal, Ashwin
    Thomas, David L.
    Thio, Chloe L.
    GASTROENTEROLOGY, 2010, 139 (06) : 1865 - 1876
  • [2] IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection
    Moghaddam, Amir
    Melum, Espen
    Reinton, Nils
    Ring-Larsen, Helmer
    Verbaan, Hans
    Bjoro, Kristian
    Dalgard, Olav
    HEPATOLOGY, 2011, 53 (03) : 746 - 754
  • [3] Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma
    Ren, Shan
    Lu, Junfeng
    Du, Xiaofei
    Huang, Yanxiang
    Ma, Lina
    Huo, Honglei
    Chen, Xinyue
    Wei, Lai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (09) : 1433 - 1439
  • [4] IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
    Ciesla, Andrzej
    Bociaga-Jasik, Monika
    Sobczyk-Krupiarz, Iwona
    Glowacki, Mikolaj K.
    Owczarek, Danuta
    Cibor, Dorota
    Sanak, Marek
    Mach, Tomasz
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4892 - 4897
  • [5] IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection
    Holmes, Jacinta A.
    Sievert, William
    Thompson, Alexander J.
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 461 - 478
  • [6] Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection
    Rembeck, Karolina
    Lagging, Martin
    PHARMACOGENOMICS, 2015, 16 (10) : 1179 - 1188
  • [7] Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C
    Sugiyama, Masaya
    Tanaka, Yasuhito
    Nakanishi, Makoto
    Mizokami, Masashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 (03) : 263 - 269
  • [8] Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
    Rauch, Andri
    Kutalik, Zoltan
    Descombes, Patrick
    Cai, Tao
    Di Iulio, Julia
    Mueller, Tobias
    Bochud, Murielle
    Battegay, Manuel
    Bernasconi, Enos
    Borovicka, Jan
    Colombo, Sara
    Cerny, Andreas
    Dufour, Jean-Francois
    Furrer, Hansjakob
    Guenthard, Huldrych F.
    Heim, Markus
    Hirschel, Bernard
    Malinverni, Raffaele
    Moradpour, Darius
    Muellhaupt, Beat
    Witteck, Andrea
    Beckmann, Jacques S.
    Berg, Thomas
    Bergmann, Sven
    Negro, Francesco
    Telenti, Amalio
    Bochud, Pierre-Yves
    GASTROENTEROLOGY, 2010, 138 (04) : 1338 - U173
  • [9] Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
    Liapakis, AnnMarie
    Jesudian, Arun B.
    PHARMACOGENOMICS, 2012, 13 (12) : 1317 - 1319
  • [10] IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population
    Dong, Zhi Xia
    Zhou, Hui Juan
    Xiang, Xiao Gang
    Guo, Si Min
    Zhuang, Yan
    Zhao, Gang De
    Xie, Qing
    JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (02) : 90 - 97
12345